AbbVie
ABBV
#32
Rank
$287.34 B
Marketcap
$162.28
Share price
-2.22%
Change (1 day)
0.56%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of April 2024 (TTM): 5.46

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.46079. At the end of 2023 the company had a P/S ratio of 5.04.

P/S ratio history for AbbVie from 2012 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.55-53.31%๐Ÿ‡บ๐Ÿ‡ธ USA
21.2 287.56%๐Ÿ‡บ๐Ÿ‡ธ USA
5.13-6.00%๐Ÿ‡บ๐Ÿ‡ธ USA
3.01-44.88%๐Ÿ‡บ๐Ÿ‡ธ USA
3.16-42.19%๐Ÿ‡บ๐Ÿ‡ธ USA
2.21-59.49%๐Ÿ‡บ๐Ÿ‡ธ USA
4.70-13.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
2.21-59.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
7.17 31.26%๐Ÿ‡บ๐Ÿ‡ธ USA